Hjem › Multipelt myelom › New Jersey › Clifton
Multipelt myelom kliniske forsøg i Clifton, NJ
14 studier for Multipelt myelom søger deltagere på steder i og omkring Clifton (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
RekruttererFase 1/2
- Hackensack University Medical Center, Hackensack · 7 mi væk
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
RekruttererFase 4
- Hackensack University Medical Center, Hackensack · 7 mi væk
Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma
RekruttererFase 1
- Hackensack Meridian Health - John Theurer Cancer Center, Hackensack · 7 mi væk
A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma
RekruttererFase 2
- John Theurer Cancer Center, Hackensack · 7 mi væk
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
RekruttererFase 3
- Hackensack Meridian Health, Hackensack · 7 mi væk
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma
RekruttererFase 1/2
- Hackensack University Medical Center, Hackensack · 7 mi væk
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
RekruttererFase 1
- John Theurer Cancer Center, Hackensack University Medical Center, Hackensack · 7 mi væk
A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 1/2
- Research Site, Hackensack · 7 mi væk
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
RekruttererFase 1
- Hackensack University Medical Center, Hackensack · 7 mi væk
Mosaic Trial for Stem Cell Transplant Recipients
Rekrutterer
- Hackensack Meridian Health, Nutley · 3 mi væk
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
RekruttererFase 1
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi væk
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
RekruttererFase 3
- GSK Investigational Site, Hackensack · 7 mi væk
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
RekruttererFase 1
- Hackensack Meridian John Theurer Cancer Center, Hackensack · 7 mi væk
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 1/2
- John Theurer Cancer Center at Hackensack UMC, Hackensack · 7 mi væk
Multipelt myelom forsøg i andre byer
- New York City, NY60 studier
- Boston, MA42 studier
- Atlanta, GA41 studier
- Houston, TX38 studier
- Durham, NC37 studier
- Nashville, TN32 studier
- Denver, CO27 studier
- Rochester, MN24 studier
- St. Louis, MO24 studier
- Columbus, OH24 studier
- Baldwin Park, CA23 studier
- Chicago, IL22 studier
Andre studier i Clifton
- Ikke-småcellet lungecancer24 studier
- Kræft (alle typer)15 studier
- Metastatisk cancer12 studier
- Akut myeloid leukæmi12 studier
- Prostatakræft12 studier
- Brystkræft12 studier
- Ægstockræft11 studier
- Lungecancer10 studier
- Livmoderslimhindekræft8 studier
- Tripelnegativ brystkræft8 studier
- Colorektal kræft8 studier
- Pladecellekræft i hoved og hals8 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.